It will be enough doses to protect a “significant portion” of the most at-risk Americans, which are the elderly, health-care workers and people with preexisting conditions, said Dr. Moncef Slaoui. Source

JOIN NCOV.LINK NEWSLETTER

And get notified everytime we publish a new Important announcements. We will not email you often, unless there are important things that need to get in touch with you, such as added new tools or new domain names.

By subscribing, you agree with our privacy policy and our terms of service.